One more ADC deal with China: Arrivent licenses ADC from Lepu Biopharma for the treatment of colorectal, pancreatic and other GI cancers. Target undisclosed, $47M in near-term payments $AVBP ir.arrivent.com/news-release... - ThreadSky | a Reddit-style client for Bluesky

jordixiol.bsky.social • 40 days ago

One more ADC deal with China: Arrivent licenses ADC from Lepu Biopharma for the treatment of colorectal, pancreatic and other GI cancers. Target undisclosed, $47M in near-term payments

$AVBP

https://ir.arrivent.com/news-releases/news-release-details/arrivent-biopharma-enters-exclusive-license-lepu-biopharma

Comments